NNC0113-6856

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Healthy ParticipantsHealthy VolunteersType 2 Diabetes

Phase 1

A Research Study of a New Medicine NNC0113-6856 in Healthy Males

CompletedNCT05521256

Novo Nordisk A/SHealthy Volunteers, Type 2 Diabetes

Start: 2022-08-26End: 2023-03-27Updated: 2025-12-31

Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants

CompletedNCT06069895

Novo Nordisk A/SHealthy Participants

Start: 2023-10-04End: 2025-04-23Updated: 2025-06-18